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Introduction
Asthma is a disease characterized by episodic airﬂow
obstruction that is at least partially reversible, lung
inﬂammation, particularly in the airways’ hyper-respon-
siveness (AHR). Both the structure and function of the
airways are altered in asthma. Airway remodelling in
asthma induces not only structural changes but also
fundamental changes in the relationships between and
among various airway constituents [1].
Occupational asthma is the most commonly reported
occupational lung disease in many industrialized coun-
tries. Diisocyantes, highly reactive low molecular weight
compounds used in the production of polyurethanes, are
the most commonly identiﬁed cause of occupational
asthma, a disease that accounts for nearly 10% of all
adult-onset asthma [2].
The major diisocyanates currently in use are methy-
lene diphenyl diisocyanate (MDI), toluene diisocyanate
(TDI), hexamethylene diisocyanate (HDI) [3], which are
used in variety of industries including polyurethane foam
manufacturing, automobile body painting and repair and
plastics manufacturing. It is estimated that as many as
5% of workers exposed to diisocyanates develop asthma,
which may persist indeﬁnitely even in the absence of con-
tinued exposure [4]. Clinically, diisocyanate asthma dis-
plays similar manifestations to allergic asthma induced
by high molecular weight allergens, suggesting common
pathogenic processes, although clinical studies have high-
lighted several important differences, such as a low
association with atopy, a low prevalence of speciﬁc
immunoglobulin E (IgE) antibodies [5], a mixed T helper
1/T helper 2 response and the presence of high numbers
of antigen-speciﬁc CD8 T cells [6].
Although the pathogenic mechanism of TDI-induced
asthma is far from clear, it is regarded that speciﬁc sensi-
tization to the compound involves binding of TDI to car-
rier molecules [7–9]. Speciﬁc IgE to isocyanate has been
reported to be of beneﬁt in the diagnosis of occupational
asthma [10–12]. Particularly, IgG-1 was suggested to be
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Abstract
Toluene diisocyanate (TDI), a highly reactive industrial chemical, is one of the
leading causes of occupation-related asthma in industrialized countries. The
pathogenesis of TDI-induced asthma, however, remains not fully understood,
in part due to lack of appropriate animal models. Twenty ﬁve female BALB/c
mice (age: 8 weeks) were randomly divided into 5 groups: Ovabumin (OVA);
OVA peptide amino acid residues No. 323–339 (Pep); TDI; alum and physio-
logical saline. Mice were intraperitoneally injected with 25 lg OVA or pep
absorbed on 300 lg alum, 300 lg alum or saline on days 0, 7 and 14. For
the TDI group, mice were sensitized subcutaneously with 20 ll neat TDI on
day 0; 20 ll of TDI in olive oil (1:10) on days 7 and 14; on days 21–23.
Then each group was challenged intranasally with 20 ll of 1% OVA, 1%
Pep, 1% TDI, 10% alum and saline respectively. On day 28, mice were killed
under pentothal anesthesia. The results demonstrated that neutrophil-dominant
inﬂammation with a few eosinophil inﬁltration occurred in the peri-bronchial
and peri-vascular regions of the lungs. This was accompanied by hyperplasia/
hypertrophy of cells lining the airways and mucus production as shown by HE
staining. Positive immunohistochemical MBP staining in parenchyma was also
shown. Th2 cytokine IL-4 and IgE production were signiﬁcant increased 5
days after last challenge while IFN-c level was below the detection limit. Con-
clusion: the clear elevation of IL-4 and IgE could allow to conclude a possible
Th2-like dominated allergic response in TDI-exposed BALB/c mouse model.
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closely associated to TDI exposure and in conjugated
form can be a useful marker for progress of TDI-asthma
[12–14]. Maestrelli et al. reported that increased levels of
Th2 cytokines were detected in the airways and bronchial
mucosa of TDI asthmatics [15]. However, some authors
observed Th1-like response characterized by an increase
in the number of neutrophils and the levels of IFN-c and
IL-8 [16–18].
Because the cellular mechanisms responsible for diis-
ocyanate-induced asthma and the determinants of expo-
sure are not fully deﬁned, diagnosis and control have
been difﬁcult. To help addressing these issues, we
developed a murine model of toluene diisocyanate
hypersensitivity, in which we used intraperitoneal injec-
tion for sensitization and intranasal administration to
challenge the airways.
Materials and methods
Experimental animals. Female BALB/c mice (approxi-
mately 20 g and 8 weeks old) were obtained from Vivar-
ium animal house, Haukeland University Hospital
(Bergen, Norway). They were kept in a conventional ani-
mal house with 12-h dark/light cycles. They received tap
water and pelleted pathogen-free food (Special Diet Servi-
ces, Witham, Essex, England) ad libitum. All experiment
procedures were approved by the local Ethical Committee
for Animal Experiment.
Chemicals. Toluene diisocyanate (2,4 to 2,6-isomers;
ratio, 80:20; lot S36694 311) was obtained from Merck-
Schuchardt, Hohenbrunn, Germany. Ovalbumin (elec-
trophoretic purity 99%, lot 81F-8230) was purchased
from Sigma Chemical Company, St Louis, MO, USA. An
Ovalbumin peptide amino acid residues No. 323–339
(Pep) was synthesized by semi-automatic peptide synthes-
izer (LKB Biochrom, Ltd, Cambridge, England) as des-
cribed before by Johnsen and Elsayed [19]. Imject alum
(lot E164 107) was obtained from Pierce Biochnology
Inc., Rockford, IL, USA.
Sensitization protocol. Twenty-ﬁve mice were randomly
divided into ﬁve groups: (a) Ovalbumin (OVA); (b) OVA
323–339 (Pep) [19]; (c) toluene diisocyanate (TDI); (d)
alum control; and (e) saline control.
Animals were allowed to acclimatize for 1 week and
then were actively sensitized by intraperitoneal (i.p.)
injections of 25 lg of OVA absorbed on 300 lg of alum,
25 lg of Pep absorbed on 300 lg of alum and on days
0, 7 and 14. For the TDI-mice the sensitization was done
by subcutaneous injection with 20 ll of neat TDI on day
0, 20 ll of TDI in olive oil (1:10) on days 7 and 14.
From days 21 to 23, the mice were challenged intranasal-
ly with 20 ll of 1% OVA in saline, 1% Pep in saline
and 1% TDI dissolved in ethyl acetate:olive oil (1:4)
respectively. Alum and saline control groups were sensiti-
zed and then challenged in a similar manner as OVA
group. Five days after last challenge, the mice were killed
by right ventricular exsanguination under pentothal
anaesthesia (50 mg/kg body weight, i.p.).
Extraction of bronchoalveolar lavage ﬂuid (BALF). Shortly
after exsanguination, the trachea was cannulated and the
lungs of the animals were then lavaged 3 times with aliqu-
ots of 0.5 ml sterile saline per mouse. The lavage ﬂuid col-
lected was centrifuged at 400·g to remove cells and then
stored at )20 C until it was analysed for cytokines and
IgE levels.
Quantiﬁcation of IgE. Total IgE in sera and the BAL
ﬂuid was quantiﬁed with a sandwich ELISA protocol pro-
vided by mouse IgE ELISA Quantitation Kit (Bethyl
Laboratories, Montgomery, TX, USA). Brieﬂy, the plates
were coated with afﬁnity-puriﬁed goat anti-mouse IgE
overnight at 4 C and then blocked with 1% bovine
serum albumin (BSA) in phosphate buffer saline (PBS)
for 30 min at room temperature (RT). The threefold
diluted sera or undiluted BAL ﬂuid samples and appro-
priate dilutions of a standard IgE preparation were added
into the wells, and the plates were incubated for 1 h at
RT. Sample blank wells received buffer instead of sera or
BAL ﬂuid and were treated identically. The bound IgE
was detected with polyclonal goat anti-IgE antibodies
(incubation for 1 h at 37 C), followed by horseradish
peroxidase (HRP)-conjugated goat anti-mouse antibodies.
The plates were developed by addition of tetram-
ethylbenzidine (TMB) and read in the ELISA plate reader
(Labsystem Multiskan Bichromatic, Helsinki, Finland) at
a wavelength (k) of 450 nm. The kit detection limit was
250–3.9 ng/ml.
Quantiﬁcation of IL-4 and IFN-c. IL-4 and IFN-c in
sera and the BAL ﬂuid were quantiﬁed by a sandwich
ELISA protocol (R&D Systems, Minneapolis, MN, USA).
Buffers and diluents used between steps in this assay were
provided by the same company. Brieﬂy, 96-well plates
were coated overnight with the capture antibody at 4 C
and then blocked for 1 h with 1% BSA in phosphate buf-
fer saline. Recombinant IL-4 or IFN-c standard (R&D
Systems), sera (threefold dilution for IL-4 and undiluted
for IFN-c) or undiluted BAL ﬂuid were added, and the
plates were incubated for 2 h at RT. The bound cytokines
were detected with a HRP-linked polyclonal antibody,
with an incubation period of 2 h at RT. The plates were
developed by addition of TMB substrate, followed by an
incubation of 30 min in the dark before reading them at
450 nm. The calculations were done with a programme
belonged to the plate reader. The kit detection limits for
IL-4 and IFN-c were given by the manufacturer (250–
7.8 pg/ml and 600–9.4 pg/ml respectively).
Histology. After the lavage, the lungs and heart were
removed en bloc and inﬂated with a similar volume of
10% buffered formalin (600 ll) at a constant pressure and
then immediately soaked in the same solution for approxi-
mately 24 h, and thereafter embedded in parafﬁn [20].
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Lung tissue sections (4 lm) were stained with haematoxy-
lin and eosin (HE). Immunohistochemistry was performed
with rabbit polyclonal antibody against murine major
basic protein. Brieﬂy, 4-lm lung tissue sections were
deparafﬁnized, followed by quenching of endogenous per-
oxidase activity, blocking with 1% normal goat serum
and sequentially incubated with rabbit anti-major basic
protein (MBP) (1:1000) and then incubated with biotinyl-
ated swine anti-rabbit immunoglobulin (DAKO, Glost-
rup, Denmark) diluted 1:500 in tris-buffered saline,
respectively, for 60 min at 25 C. Sections were incubated
ﬁrst with avidin–biotin–peroxidase complex (DAKO) and
then with diaminobenzidine for the development of a
coloured reaction product before being counterstained
with haematoxylin [21, 22]. Pictures were acquired with
LEICA DMLB light microscope (Leica Microsystems
GmbH, Wetzlar, Germany) and LEICA DC 300 camera,
thereafter imported into Adobe Photoshop 7 (Adobe Sys-
tems Incorporated, San Jose, CA, USA ).
Morphometric analysis. Bronchial measurements were made
at 250· magniﬁcation using LEICA Q500 MC Qwin
system (Leica Microsystems GmbH). Bronchia with a
diameter less than 250 lm that presented a smooth cir-
cular and oval proﬁle were selected. As schematically
illustrated in Fig. 1., the measurements were made across
the shortest and longest axis of the elliptical proﬁles at
the location where the cell borders appeared sharp to
minimize the inﬂuence of tangential sectioning. Measure-
ments include the lumen diameter (B, b), the diameter of
the airway between the outermost layers of smooth mus-
cle (A, a), and the thickness of the bronchial wall from
the base of the columnar epithelium to the outer limit of
the adventitia (C, c). On a subset of airways (not sharing
an extensive length of their adventitia with arteries), axes
of the elliptical proﬁles were measured. Five mice from
each group were enrolled in this measurement. C+c was
expressed as the thickness of the airway wall for group
differences analysis. The differences between individual
groups were tested by an ANOVA statistical analysis for
multiple comparison.
Data analysis. Values are presented as mean ± SD. ANO-
VA statistical analyses were performed using alum and
saline as reference category, and post hoc tests with adjust-
ments for multiple testing by the approach of Dunnet’s
T3 where equal variances within groups are not assumed.
Overall values P < 0.05 were considered to be signiﬁcant.
All tests were two-tailed. Data were analysed with SPSS
statistical software (SPSS Inc., Chicago, IL, USA).
Results
None of the animals exhibited noticeable distress or sig-
niﬁcant tachypnea during the period of study, there was
no mortality.
Cytokine and total IgE levels in serum and BALF
Five days after last intranasal challenge, blood was col-
lected from control and exposed mice. The serum was
analysed for total IgE and cytokines, IL-4 and IFN-c
levels (Table 1). There was a statistically signiﬁcant
increase in IL-4 level in the mice intraperitoneally sensi-
tized and thereafter intranasally challenged by TDI,
OVA and Pep, respectively, compared with saline or
alum controls.
Table 1 IgE and cytokines level in sera
(mean ± SD, n ¼ 5)
TDI OVA OVA 323–339
Reference
Alum Saline
IL-4 (pg/ml) 75.3 ± 41.9* 37.3 ± 21.4* 71.9 ± 42.0* 0
IL-4 (pg/ml) 75.3 ± 41.9* 37.3 ± 21.4* 71.9 ± 42.0* 0
IgE (ng/ml) 98.1 ± 16.0* 91.3 ± 9.2* 7.9 ± 7.1 7.3 ± 4.7
IgE (ng/ml) 98.1 ± 16.0* 91.3 ± 9.2* 7.9 ± 7.1 8.7 ± 7.3
IFN-c (pg/ml) UD UD UD UD UD
*ANOVA, compared with alum and saline control, P < 0.01. OVA, ovalbumin; UD, under detec-
tion limit.
A
B C
c
b
a
Epithelium
Smooth muscle
Figure 1 Schematic representation of variables for airway wall morpho-
metric analysis. A ¼ maximum external (transverse) diameter; a ¼
minimum external (transverse) diameter; B ¼ maximum lumen diam-
eter; b ¼ minimum lumen diameter; C ¼ airway wall thickness calcula-
ted from A and B; c ¼ airway wall thickness calculated from a and b.
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When compared with alum and saline controls,
13- and 11-fold increase of serum total IgE were, respect-
ively, found in TDI-treated mice while 12.5- and 10.5-
fold were found in OVA-treated animals. As for Pep
group, no increase of IgE was found when compared with
the control animals. Statistically no signiﬁcant difference
was found between two control groups.
Non-detectable levels of IL-4 and IFN-c in BALF
were obtained under the experimental conditions used.
Histology
Histology of the lung tissue was performed 5 days after
ﬁnal challenge; the saline- and alum-exposed mice dem-
onstrated normal lung morphology. In contrast, histolog-
ical sections of lung tissue from TDI-exposed mice
exhibited pulmonary inﬂammation, inﬁltrating neutroph-
ils accompanied by macrophages, lymphocytes and a few
eosinophils were mainly observed in the peri-bronchial
and peri-vascular regions of the lungs. The increased
neutrophils should be responsible for the cell recruit-
ment in lung. Comparatively the mice sensitized by OVA
demonstrated a typical eosinophil-dominant inﬂammation
as well as Pep-treated mice (eosinophils were visualized
by Congo red staining). Thickening of the bronchial wall
and increased mucus production were shown by HE
staining in TDI-, OVA- and Pep-exposed mice (Fig. 2).
For the 4-lm bronchial lung sections incubated with
anti-MBP, there were large number of neutrophils in the
parenchyma, and intense MBP staining of the apical sur-
faces of respiratory epithelial cells for the animals treated
by OVA, Pep and TDI. In contrast, fewer neutrophils
and eosinophils inﬁltration were observed in saline and
alum control animals, and even less MBP staining around
the airways (Fig. 3).
Airway wall alternations
On light microscopic examination, the walls of the
bronchia from the sensitized mice were thickened when
Figure 2 Photomicrograghs of lung tissue
sections from different animal groups. Five
days after last challenge, lung tissue from
treated groups and controls were sectioned
and haematoxylin/eosin staining was done. C:
saline control mice; alum: alum control mice;
OVA: mice immunized with OVA; Pep: mice
immunized with Pep; TDI: mice immunized
with TDI. Original magniﬁcation: 200·.
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compared with control mice. TDI-treated mice showed,
at least partly, a similar change in airway remodelling as
Pep-treated mice and OVA-treated animals (Fig. 4).
Discussion
Asthma is a chronic respiratory disease characterized by
the presence of reversible airway constriction and AHR
to various stimuli [23]. AHR is a cardinal feature of the
disease in which acute airway narrowing is easily elicited
by non-speciﬁc stimuli, such as exercise, cold air or inha-
lation airway irritants, such as histamine or metacholine
[24]. Underlying the clinical manifestations is a acute-
on-chronic inﬂammation of airway mucosa, with degran-
ulation of mast cells, recruitment of eosinophils and
neutrophils, as well as accumulation of activated
T lymphocytes and other chronic inﬂammatory cells [25].
Several studies of airway inﬂammation in non-occupa-
tional asthmatic subjects have reported heterogeneity of
cell counts. Wenzel et al. reported two pathophysiological
subtypes amongst severe asthmatics, i.e. the ones with
and without evidence of eosinophil inﬁltration in bron-
chial biopsy specimens [26, 27]. More recent studies
Figure 3 Presentation of major basic protein
(MBP) by immunohistochemistry staining in
the lung tissue of allergen-treated mice. C:
saline control animals; alum: alum control
animal; OVA: animals sensitized with OVA;
Pep: animals sensitized with Pep; TDI: ani-
mals sensitized with TDI. Mice were sacri-
ﬁced 5 days after challenge, and 4 lm lung
sections were incubated with anti-MBP. The
ﬁgure is representative of ﬁve animals each
group. MBP immunohistochemistry staining.
Original magniﬁcation: 200·.
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Figure 4 The thickening of the airway wall in allergen-treated mice.
Compared with saline and alum controls, TDI, OVA and Peptide OVA
323–339 sensitized mice demonstrated a signiﬁcant increase in airway
wall thickness 28 days after combination of intraperitoneal injection
sensitization and intranasal challenge with different allergens. Compared
with alum and saline controls, P < 0.05.
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where airway inﬂammation has been assessed non-
invasively using induced sputum on diverse range of
patients have shown predominant neutrophilic airway
inﬂammation in some patients with severe asthma.
Whether these changes reﬂect the severity of the disease
or the effect of treatment was unclear [28, 29].
Although animal models are not always closely
reﬂective of human responses, it could certainly improve
our understandings of the cellular and molecular mech-
anism associated with TDI-induced allergic disorders
[30]. TDI is capable of inducing different types of
immune reactions, depending on T-cell polarization
toward the helper type 1 (Th1) or helper type 2 (Th2)
cells. Th1 cells promote cell-mediated immunity and are
deﬁned by their secretion of cytokines, mainly IFN-c.
Th2 cells are recognized by the secretion of interleukins,
such as IL-4, IL-5 and IL-13, which support humoral
immune response. In experimental studies, the diver-
gence might be because of different animal experimenta-
tion conditions, e.g. sensitization way and dose applied
[31]. Up to now, concerning the mechanism for TDI
asthma, especially the Th1 or Th2 type responses, the
published results remain controversial [31]. BALB/c
mouse is frequently employed in studies of respiratory
allergy. In case of occupational asthma, this model has
commonly been used for studies for Th2 phenotype-
induced diseases.
Previous morphological examination of airway tissue
from patients who died of severe bronchial asthma has
revealed abnormalities in the airways, which was thought
to be, in part, irreversible [32]. These include goblet cell
hyperplasia, sub-epithelial ﬁbrosis and smooth muscle
cell hyperplasia/hypertrophy. It is generally accepted that
tissue remodelling is a process of wound healing for the
maintenance of homeostasis after various injuries. These
processes normally contribute to the repair of injured tis-
sues, not only morphologically, but also functionally.
However, the results of chronic airway inﬂammation may
induce airway remodelling which may differ from wound
healing, leading to airway narrowing and ﬂow limitation.
Th2 cells produce IL-4 which is closely related to the
promotion of IgE production. IL-4 is also well known as
a key cytokine in the development of T cells, especially
Th2 type [33].
The main objective of this study was to elucidate the
events involved in airway remodelling on the basis of a
newly established animal model at our laboratory.
We demonstrated that repetitive allergen and TDI
airway exposure induced marked increases in the
inﬂammatory leukocytes, especially eosinophils and neu-
trophils in lung tissue and IL-4 secretion. In contrast,
the IFN-c level was low and undetectable under the
experimental method used. Paralleling IL-4 production
and IgE synthesis signiﬁcantly increased after exposure
both in TDI and OVA mice. In case of OVA 323–
339 sensitized mice, low IgE titer was found. OVA
323–339, known to be MHC Ia-binding peptide, did
not enhance IgE synthesis compared with the intact
molecule. Possible explanation for this lower IgE in
OVA 323–339 may be contributed to variable genetic
subsets of BALB/c mice MHC, afﬁnity of the ligand or
carriers needed for a successful in vivo immune reaction
[19].
Respiratory responses to TDI as well as MDI [34]
only occur upon a previous contact with the same anti-
gens. As generally known, the frequency and the con-
centration of sensitization prior to challenge affects the
subsequent response to intranasal exposure to TDI in a
complicated pathway [35]. Moreover, strain differences
are known in the patterns of mRNA expression of
cytokines or receptors, for example, BALB/c mice tend
to exhibit higher IL-4 mRNA expression than C57BL/6
mice even when treated with Th1-predominant aller-
gens, such as dinitrochlorobenzene (DNCB) and trimel-
litic anhydride (TMA) [36, 37]. Conversely, C57BL/6
mice show higher IFN-c levels with the application of
DNCB than does the BALB/c strain, namely C57BL/6
mice and BALB/c mice are Th1 and Th2 predominant
respectively [38, 39].
These results reported are in line with previous reports:
BALB/c mice are more likely to present Th2 dominant
response, for which the underlying mechanisms are still
obscure; however, partly attributable to the BALB/c mouse
genetic control of IL-4 production [36]. In this study, we
have focused on the speciﬁc immune response of chemic-
ally induced hypersensitivity. Cell composition data from
BAL and airway function measurements, for new experi-
ments, will be reported separately. Additionally better
timing of autopsies and a revised approach for a semi-
quantitative grading for the histological sections on the
basis of arbitrary scores, are to be considered. Neverthe-
less, few additional controls would be necessary for further
validation of the model, e.g. non-sensitized and sensitized
but not challenged groups.
Although the present model may not demonstrate com-
plete features of TDI-induced occupational asthma, the
ﬁndings demonstrate that the development of airway
remodelling, including hyperplasia/hypertrophy of the cell
lining in the airways and the hyper-secretion of the mucus,
probably is the result of Th2-like IgE-dependent neutro-
phil-dominant inﬂammation. In TDI-exposed allergic
BALB/c mouse model, the observed neutrophil-dominant
reaction is different from Th2-dominated IgE-dependent
eosinophil inﬂammation which is commonly developed in
OVA-induced murine asthma models. TDI-induced
inﬂammation is composed of inﬁltrating neutrophils,
macrophages and lymphocytes, which is consistent with
the reports of TDI asthma in humans. Unlike humans,
however, eosinophils could be very minimal or even absent
[40, 41].
6 Airway Inﬂammation and Remodelling in TDI-exposed BALB/c Mouse Model L.-Z. Sun et al.
..................................................................................................................................................................
 2006 The Authors
Journal compilation  2006 Blackwell Publishing Ltd. Scandinavian Journal of Immunology
Similarly, in workplaces, TDI-induced asthma may
result from a previous contact with TDI, some of which
might initiate allergic sensitization associated with type
2 cytokine production and high IgE levels [31].
Taken together, this study indicates that BALB/c
mouse as a Th2-like model of TDI-induced airway
allergy may, in several aspects, mimic occupational TDI
asthma in humans.
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